Panagora Asset Management Inc P Lx Pharma Inc. Transaction History

Panagora Asset Management Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$1.22 - $4.38 $1,967 - $7,064	-1,613 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$3.18 - $5.15 $823 - $1,333	-259 Reduced 13.84%	1,613 $7,000
Q2 2018 Aug 14, 2018	BUY	$3.3 - $4.5 $6,177 - $8,424	1,872 New	1,872 $7,000

62.7K

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.